![Jens Kjeldsen-Kragh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Jens Kjeldsen-Kragh is the founder and Chief Scientific Officer at Prophylix AS, a company he founded in 2008.
He held the position since 2010.
Additionally, he worked as a Professor at the University of Oslo in his former job(s).
Posizioni attive di Jens Kjeldsen-Kragh
Società | Posizione | Inizio |
---|---|---|
Prophylix AS
![]() Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Fondatore | 01/01/2008 |
Precedenti posizioni note di Jens Kjeldsen-Kragh
Società | Posizione | Fine |
---|---|---|
University of Oslo | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Prophylix AS
![]() Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Health Technology |
- Borsa valori
- Insiders
- Jens Kjeldsen-Kragh